Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,570
Closed -$261K 252
2022
Q3
$261K Hold
1,570
﹤0.01% 212
2022
Q2
$324K Hold
1,570
﹤0.01% 195
2022
Q1
$380K Hold
1,570
﹤0.01% 205
2021
Q4
$382K Hold
1,570
﹤0.01% 203
2021
Q3
$321K Hold
1,570
﹤0.01% 199
2021
Q2
$324K Sell
1,570
-6
-0.4% -$1.21K ﹤0.01% 202
2021
Q1
$300K Hold
1,576
﹤0.01% 204
2020
Q4
$299K Hold
1,576
﹤0.01% 197
2020
Q3
$278K Sell
1,576
-275
-15% -$44K ﹤0.01% 192
2020
Q2
$284K Sell
1,851
-1,600
-46% -$244K ﹤0.01% 172
2020
Q1
$483K Hold
3,451
0.01% 151
2019
Q4
$526K Sell
3,451
-2,900
-46% -$425K 0.01% 168
2019
Q3
$918K Hold
6,351
0.02% 140
2019
Q2
$946K Hold
6,351
0.02% 144
2019
Q1
$813K Sell
6,351
-56
-0.9% -$6.59K 0.02% 155
2018
Q4
$685K Hold
6,407
0.02% 163
2018
Q3
$733K Hold
6,407
0.02% 172
2018
Q2
$673K Sell
6,407
-183
-3% -$18.4K 0.02% 165
2018
Q1
$615K Sell
6,590
-394,713
-98% -$35.9M 0.01% 176
2017
Q4
$35.1M Sell
401,303
-352,189
-47% -$31.4M 0.88% 38
2017
Q3
$66.6M Sell
753,492
-156,274
-17% -$13.2M 1.73% 29
2017
Q2
$74.1M Sell
909,766
-23,403
-3% -$1.78M 1.96% 24
2017
Q1
$64.8M Buy
933,169
+187,295
+25% +$13M 1.83% 28
2016
Q4
$50.3M Buy
+745,874
New +$50.6M 1.41% 32

Other funds holding STE

DF Dent & Co's STE Position: Q4 2022 in Review

DF Dent & Co sold out of Steris (STE) in Q4 2022, closing a stake of 1,570 shares — an estimated $261K sold.

DF Dent & Co first reported a position in STE in Q4 2016 and held it in 24 quarters. The position peaked at $74.1M in Q2 2017. 648 funds tracked by Wall St. Rank hold STE as of Q4 2022.

  • DF Dent & Co reported no remaining Steris position as of Q4 2022 after selling out during the quarter.
  • DF Dent & Co sold 1,570 Steris shares in Q4 2022, an estimated $261K.
  • DF Dent & Co first reported a position in Steris in Q4 2016 and held it in 24 quarters.
  • DF Dent & Co's Steris position peaked at $74.1M in Q2 2017.
  • 648 funds tracked by Wall St. Rank held Steris as of Q4 2022.

Based on DF Dent & Co's 13F filing for Q4 2022, filed 15 Feb 2023.